These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37653377)

  • 1. Who cares about migraine? Pathways and hurdles in the European region - access to care III.
    Vaghi G; De Icco R; Tassorelli C; Goadsby PJ; Vicente-Herrero T; de la Torre ER
    J Headache Pain; 2023 Sep; 24(1):120. PubMed ID: 37653377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life: Results of the OVERCOME (US) Study.
    Shapiro RE; Nicholson RA; Seng EK; Buse DC; Reed ML; Zagar AJ; Ashina S; Muenzel EJ; Hutchinson S; Pearlman EM; Lipton RB
    Neurology; 2024 Feb; 102(3):e208074. PubMed ID: 38232340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of migraine and unmet needs from the patients' perspective: a survey across 11 specialized headache clinics in Korea.
    Kim BK; Chu MK; Yu SJ; Dell'Agnello G; Han JH; Cho SJ
    J Headache Pain; 2021 May; 22(1):45. PubMed ID: 34030630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort : Results from 'Migraine in Poland'-a nationwide cross-sectional survey.
    Waliszewska-Prosół M; Straburzyński M; Czapińska-Ciepiela EK; Nowaczewska M; Gryglas-Dworak A; Budrewicz S
    J Headache Pain; 2023 Apr; 24(1):40. PubMed ID: 37041492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
    Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organization.
    Mitchell MP; Schaecher K; Cannon HE; Speckman M
    J Manag Care Pharm; 2008 Jun; 14(5):442-50. PubMed ID: 18597573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden and costs of migraine in a Swedish defined patient population - a questionnaire-based study.
    Hjalte F; Olofsson S; Persson U; Linde M
    J Headache Pain; 2019 May; 20(1):65. PubMed ID: 31151382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of migraine related to menses: results from the AMPP study.
    Pavlović JM; Stewart WF; Bruce CA; Gorman JA; Sun H; Buse DC; Lipton RB
    J Headache Pain; 2015 Mar; 16():24. PubMed ID: 25902814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study.
    Evers S; Dell'Agnello G; Novick D; Gonderten HS; Panni T; Pascual J
    Pain Ther; 2024 Jun; 13(3):589-607. PubMed ID: 38625512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A narrative review on the burden of migraine: when the burden is the impact on people's life.
    Leonardi M; Raggi A
    J Headache Pain; 2019 Apr; 20(1):41. PubMed ID: 31023226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of migraine in a Kuwaiti population: a door-to-door survey.
    Al-Hashel JY; Ahmed SF; Alroughani R
    J Headache Pain; 2017 Oct; 18(1):105. PubMed ID: 29030731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA).
    Sacco S; Braschinsky M; Ducros A; Lampl C; Little P; van den Brink AM; Pozo-Rosich P; Reuter U; de la Torre ER; Sanchez Del Rio M; Sinclair AJ; Katsarava Z; Martelletti P
    J Headache Pain; 2020 Jun; 21(1):76. PubMed ID: 32546227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial.
    Schwedt TJ; Hentz JG; Sahai-Srivastava S; Spare NM; Martin VT; Treppendahl C; Digre K; Bennett NL; Birlea M; Watson D; Murinova N; Robert T; Dodick DW;
    Headache; 2021 Feb; 61(2):351-362. PubMed ID: 33432635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features.
    Lipton RB; Serrano D; Holland S; Fanning KM; Reed ML; Buse DC
    Headache; 2013 Jan; 53(1):81-92. PubMed ID: 23078241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
    Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S
    Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global trends in migraine care: results from the MAZE survey.
    Brandes JL
    CNS Drugs; 2002; 16 Suppl 1():13-8. PubMed ID: 12196035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.